Emily Reeve

Dr Emily Reeve

School of Pharmacy and Biomedical Science

College of Health

I am a Senior Research Fellow and Senior Lecturer of Pharmacy Practice (at UniSA since 2019). I am currently funded by an NHMRC Investigator Grant (EL2: 2021-2025). I am also a qualified pharmacist with experience working as a clinical pharmacist in a large tertiary teaching hospital. I completed my PhD at the University of South Australia in 2014 and was awarded the medal from the School of Pharmacy and Medical Sciences for my thesis work. Following this I was a postdoctoral research associate at the University of Sydney with the NHMRC Cognitive Decline Partnership Centre. I also spent two months as a visiting researcher at the Brocher Foundation (Geneva, Switzerland) in 2014. I also previously held an NHMRC-ARC Dementia Research Development Fellowship. The first two years of this fellowship were undertaken in Canada with the University of Sydney and the Department of Medicine at Dalhousie University, with the final two years completed at UniSA. I hold affiliate status with the College of Pharmacy, Dalhousie University. 

My research focuses on optimizing medication use in older adults and people living with dementia and/or frailty. In particular, I conduct research in the field of deprescribing, the process of withdrawal of inappropriate medications, supervised by a healthcare professional with the aim of reducing polypharmacy and optimising health outcomes.

Year Citation
2026 Fraser, L., Wiese, M. D., Ailabouni, N., Ellett, L. K., Sirois, C., Berthelot, W., . . . Reeve, E. (2026). Patients’ attitudes towards deprescribing disease modifying anti-rheumatic drugs in rheumatoid arthritis. Patient Education and Counseling, 143(109432), 109432.
DOI
2025 Langford, A. V., Warriach, I., McEvoy, A. M., Karaim, E., Chand, S., Turner, J. P., . . . Reeve, E. (2025). What do clinical practice guidelines say about deprescribing? A scoping review. BMJ Quality and Safety, 34(1), 017101-1-017101-12.
DOI Scopus19 WoS21 Europe PMC17
2025 Law, R., Gupta, N., Langford, A. V., & Reeve, E. (2025). Attitudes of Australian patients receiving inpatient mental health care towards deprescribing: a cross-sectional survey. BMC Psychiatry, 25(1, article no. 269), 1-11.
DOI Scopus1
2025 Reeve, E., Cowan, K., Kalisch Ellett, L., Sinclair, R., Nguyen, T. A., Sluggett, J. K., & Ailabouni, N. (2025). Top 10 consumer and healthcare professional priorities for research in the field of quality use of medicines in people living with dementia. Journal of Alzheimer's Disease, 107(1), 207-222.
DOI
2025 Wallis, J. A., Langford, A. V., O'Connor, D., Reeve, E., Ackerman, I. N., Haas, R., . . . Buchbinder, R. (2025). Implementation interventions to promote healthcare professional uptake of evidence-based opioid prescribing for adults with acute non-cancer pain. Cochrane Database of Systematic Reviews, 2025(7), CD016179.
DOI
2025 Fraser, L., Ailabouni, N., Ellett, L. K., Tan, J. M., Freeman, A., Proudman, S. M., . . . Wiese, M. D. (2025). A scoping review of disease-modifying antirheumatic drug nonadherence in rheumatoid arthritis: Measurement, prevalence and implications for clinical practice. British Journal of Clinical Pharmacology, online(12), 1-11.
DOI Europe PMC1
2025 Mellors, D., Antonas, D., Russell, P., Arunasalam, H., Ailabouni, N., Koeper, I., & Reeve, E. (2025). Hospital readmissions related to adverse drug withdrawal events in older adults: a pilot study. International Journal Of Clinical Pharmacy, online, 1-17.
DOI
2025 Tan, J. M., Desforges, K., Chai, W. C., Proudman, S. M., Wiese, M. D., & Reeve, E. (2025). Perspectives of patients with rheumatoid arthritis towards the use of parenteral methotrexate: a qualitative study. International Journal Of Clinical Pharmacy, online, 1-12.
DOI Europe PMC1
2025 Mehta, H. B., Sekhon, V. K., Reeve, E., Sheehan, O. C., Boyd, C. M., & Green, A. R. (2025). Exploring the association between intention and action in deprescribing. Journal of the American Geriatrics Society, 73(4), 1297-1300.
DOI
2025 Fried, T. R., Ouyang, N., Gnjidic, D., Green, A., Hilmer, S., Holmes, H. M., . . . Funaro, M. C. (2025). Communication as a key component of deprescribing: conceptual framework and review of the literature. Journal of the American Geriatrics Society, 73(3), 717-727.
DOI
2025 Maher, D., Reeve, E., & Wiese, M. (2025). Reply. Arthritis Care and Research, 77(7), 939-940.
DOI
2025 Gnjidic, D., Langford, A. V., Jordan, V., Sawan, M., Sheppard, J. P., Thompson, W., . . . Reeve, E. (2025). Withdrawal of antihypertensive drugs in older people. Cochrane Database of Systematic Reviews, 2025(3), 1-66.
DOI
2025 Lord, L., Langford, A., Wang, T., Shaw, G., Ilomaki, J., Reeve, E., & Turner, J. (2025). Barriers and enablers to deprescribing for people living with cystic fibrosis: multidisciplinary perspectives. Respiratory Medicine, 242(108091), 1-7.
DOI
2025 Goordeen, D., Bell, J. S., Elsedfy, Y., Fariman, S., Hamada, S., Hattori, Y., . . . Reeve, E. (2025). Diabetes medication management recommendations for older adults: a systematic review of the Western Pacific region. Geriatrics and Gerontology International, 25(6), 717-729.
DOI
2025 Bayliss, E. A., Goodrich, G. K., Barrow, J. C., Harding, B., Ripley, C. A., Kraus, C. R., . . . Boyd, C. M. (2025). Discontinuation categories underlying gaps in dispensing for six medication groups. Pharmacoepidemiology and Drug Safety, 34(4), 1-10.
DOI Scopus3 WoS3 Europe PMC3
2025 McEvoy, A. M., Langford, A. V., Liau, S. J., Goordeen, D., Reeve, E., & Turner, J. P. (2025). Deprescribing Benzodiazepine receptor agonists in older adults and people with cognitive impairment: a systematic review. Journal of the American Geriatrics Society, online(9), 1-9.
DOI
2025 Vidonscky Luethold, R., Jungo, K. T., Weir, K. R., Adler, L., Reeve, E., & Streit, S. (2025). Older adults' attitudes toward deprescribing in 14 Countries. Jama Network Open, 8(2), 1-15.
DOI
2025 Langford, A. V., Wallis, J. A., Reeve, E., Buchbinder, R., Cross, A. J., Turner, J., . . . O'Connor, D. (2025). Implementation interventions to promote healthcare professional uptake of evidence-based opioid deprescribing for adults with chronic non-cancer pain. Cochrane Database of Systematic Reviews, 2025(7), CD016178.
DOI
2024 Lim, A., Abeyaratne, C., Reeve, E., Desforges, K., & Malone, D. (2024). Using Kane's validity framework to compare an integrated and single-skill objective structured clinical examination. American Journal of Pharmaceutical Education, 88(9, article no. 100756), 1-6.
DOI
2024 Chua, S., Todd, A., Reeve, E., Smith, S. M., Fox, J., Elsisi, Z., . . . Gray, S. L. (2024). Deprescribing interventions in older adults: An overview of systematic reviews. PLoS ONE, 19(6, article no. e0305215), 1-20.
DOI Scopus9 WoS10 Europe PMC10
2024 Ailabouni, N. J., Weir, K. R., Brandt, N., Hanjani, L. S., Green, A., Thompson, W., . . . Reeve, E. (2024). Partnering with a stakeholder steering group to co-design the PRIME deprescribing conversation tool: reflections and recommendations. Basic & Clinical Pharmacology & Toxicology, 134(1), 121-125.
DOI
2024 Boyd, C. M., Shetterly, S. M., Powers, J. D., Weffald, L. A., Green, A. R., Sheehan, O. C., . . . Bayliss, E. A. (2024). Evaluating the safety of an educational deprescribing intervention: lessons from the optimize trial. Drugs and Aging, 41(1), 45-54.
DOI Scopus8 WoS8 Europe PMC7
2024 Langford, A. V., Bero, L., Lin, C. W. C., Blyth, F. M., Doctor, J. N., Holliday, S., . . . Schneider, C. R. (2024). Context matters: using an Evidence to Decision (EtD) framework to develop and encourage uptake of opioid deprescribing guideline recommendations at the point-of-care. Journal of Clinical Epidemiology, 165(111204), 1-10.
DOI Scopus5 WoS4 Europe PMC4
2024 Langford, A. V., Schneider, C. R., Reeve, E., Doctor, J. N., & Gnjidic, D. (2024). Comment on: 'Patient perceptions of opioids and benzodiazepines and attitudes toward deprescribing'. Drugs and Aging, 41(1), 77-78.
DOI
2024 McDonald, E. G., Lundby, C., Thompson, W., Boyd, C., Farrell, B., Gagnon, C., . . . Reeve, E. (2024). Reducing potentially inappropriate polypharmacy at a national and international level: the impact of deprescribing networks. Expert Review of Clinical Pharmacology, 17(5-6), 433-440.
DOI Europe PMC2
2024 Reeve, E., Gnjidic, D., Langford, A. V., & Hilmer, S. N. (2024). Deprescribing antihypertensive drugs in frail older adults. Australian Prescriber, 47(3), 85-90.
DOI
2024 Ailabouni, N. J., Thompson, W., Hilmer, S. N., Quirke, L., McNeece, J., Bourke, A., . . . Reeve, E. (2024). Co-designing a consult patient decision aid for continuation versus deprescribing cholinesterase inhibitors in people living with dementia. Drugs and Aging, 41(10), 821-831.
DOI
2024 Langford, A. V., Schneider, C. R., Reeve, E., & Gnjidic, D. (2024). Minimising harm and managing pain: deprescribing Opioids in older adults. Drugs and Aging, 41(11), 863-871.
DOI
2024 Maher, D., Reeve, E., Hopkins, A., Tan, J. M., Tantiongco, M., Ailabouni, N., . . . Wiese, M. (2024). Comparative Risk of Gout Flares When Initiating or Escalating Various Urate-Lowering Therapy: A Systematic Review With Network Meta-Analysis. Arthritis Care and Research, 76(6), 871-881.
DOI Scopus7 WoS7 Europe PMC2
2024 Dowd, L. A., Hamada, S., Hattori, Y., Veal, F. C., Taguchi, R., Sakata, N., . . . Cross, A. J. (2024). A mixed-methods study on the pharmacological management of pain in Australian and Japanese nursing homes. Age and Ageing, 53(2), afae024-1-afae024-13.
DOI Scopus5 WoS4 Europe PMC4
2023 Tan, J. M., Reeve, E., Fraser, L., Proudman, S. M., & Wiese, M. D. (2023). The Barriers and Enablers to the Use of Parenteral Methotrexate in Rheumatoid Arthritis Patients: A Scoping Review. Arthritis Care and Research, 75(11), 2306-2315.
DOI Scopus2 WoS2 Europe PMC2
2023 Norton, J. D., Zeng, C., Bayliss, E. A., Shetterly, S. M., Williams, N., Reeve, E., . . . Boyd, C. M. (2023). Ethical aspects of physician decision-making for deprescribing among older adults with dementia. JAMA network open, 6(10), 1-14.
DOI Scopus7 WoS7 Europe PMC6
2023 Reeve, E., Chenoweth, L., Sawan, M., Nguyen, T. A., Kalisch Ellett, L., Gilmartin-Thomas, J., . . . Hilmer, S. N. (2023). Consumer and Healthcare Professional Led Priority Setting for Quality Use of Medicines in People with Dementia: Gathering Unanswered Research Questions. Journal of Alzheimer S Disease, 91(3), 933-960.
DOI Scopus6 WoS5 Europe PMC4
2023 Sheehan, O. C., Gleason, K. S., Bayliss, E. A., Green, A. R., Drace, M. L., Norton, J., . . . Boyd, C. M. (2023). Intervention design in cognitively impaired populations-lessons learned from the OPTIMIZE deprescribing pragmatic trial. Journal Of The American Geriatrics Society, 71(3), 774-784.
DOI Scopus6 WoS8 Europe PMC6
2023 Reeve, E., Bayliss, E. A., Shetterly, S., Maiyani, M., Gleason, K. S., Norton, J. D., . . . Boyd, C. M. (2023). Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed. Age and ageing, 52(1), 1-9.
DOI Scopus11 WoS10 Europe PMC10
2023 Reeve, E., Thompson, W., Boyd, C., Lundby, C., & Steinman, M. A. (2023). The state of deprescribing research: how did we get here?. Basic & Clinical Pharmacology & Toxicology, 133(6), 657-660.
DOI Europe PMC6
2023 Thompson, W., Reeve, E., McDonald, E. G., Farrell, B., Scott, S., Steinman, M. A., . . . Lundby, C. (2023). Ten deprescribing articles you should know about: a guide for newcomers to the field. Basic & Clinical Pharmacology & Toxicology, 133(6), 661-664.
DOI
2023 Fujita, K., Hooper, P., Masnoon, N., Lo, S., Gnjidic, D., Etherton Beer, C., . . . Hilmer, S. N. (2023). Impact of a comprehensive intervention bundle including the drug burden index on deprescribing anticholinergic and sedative drugs in older acute inpatients: a non-randomised controlled before-and-after pilot study. Drugs and Aging, 40(7), 633-642.
DOI
2023 Langford, A. V., Lin, C. C. W., Bero, L., Blyth, F. M., Doctor, J., Holliday, S., . . . Gnjidic, D. (2023). Clinical practice guideline for deprescribing opioid analgesics: summary of recommendations. Medical Journal of Australia, 219(2), 80-88.
DOI Scopus42 WoS37 Europe PMC29
2023 Bucsa, C., Onea, M., Rusu, A., Farcas, A., Porojan, M., Dumitrascu, D., . . . Moga, D. (2023). Translation, cultural adaptation and validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire in Romanian older adults. Research in Social and Administrative Pharmacy, 19(11), 1471-1479.
DOI
2023 Spinewine, A., Reeve, E., & Thompson, W. (2023). Revisiting systematic reviews on deprescribing trials to better inform future practice and research. British Journal of Clinical Pharmacology, 89(12), 3758-3764.
DOI
2022 Ailabouni, N. J., Weir, K. R., Reeve, E., Turner, J. T., Wilson Norton, J., & Gray, S. L. (2022). Barriers and enablers of older adults initiating a deprescribing conversation. Patient Education and Counseling, 105(3), 615-624.
DOI
2022 Weir, K. R., Ailabouni, N. J., Schneider, C. R., Hilmer, S. N., & Reeve, E. (2022). Considerations for systematic reviews of quantitative surveys: learnings from a systematic review of the patients' attitudes towards deprescribing questionnaire. Research in Social and Administrative Pharmacy, 18(2), 2345-2349.
DOI
2022 Bai, I., Isenor, J. E., Reeve, E., Whelan, A. M., Martin Misener, R., Burgess, S., & Kennie Kaulbach, N. (2022). Using the behavior change wheel to link published deprescribing strategies to identified local primary healthcare needs. Research in Social and Administrative Pharmacy, 18(8), 3350-3357.
DOI
2022 Bayliss, E. A., Shetterly, S. M., Drace, M. L., Norton, J. D., Maiyani, M., Gleason, K. S., . . . Boyd, C. M. (2022). Deprescribing education vs usual care for patients with cognitive impairment and primary care clinicians: the OPTIMIZE pragmatic cluster randomized trial. JAMA Internal Medicine, 182(5), 534-542.
DOI Scopus67 WoS67 Europe PMC68
2022 Shrestha, S., Poudel, A., Reeve, E., Linsky, A. M., Steadman, K. J., & Nissen, L. M. (2022). Development and validation of a tool to understand health care professionals' attitudes towards deprescribing (HATD) in older adults with limited life expectancy. Research In Social & Administrative Pharmacy, 18(9), 3596-3601.
DOI
2022 Scott, I. A., Reeve, E., & Hilmer, S. N. (2022). Establishing the worth of deprescribing inappropriate medications: are we there yet?. Medical Journal of Australia, 217(6), 283-286.
DOI
2022 Gnjidic, D., Johansson, M., Meng, D. M., Farrell, B., Langford, A., & Reeve, E. (2022). Achieving sustainable healthcare through deprescribing. The Cochrane database of systematic reviews, 10(10), 1-3.
DOI
2022 Turner, J. P., Thompson, W., Reeve, E., & Bell, J. S. (2022). Deprescribing proton pump inhibitors. Australian journal of general practice, 51(11), 845-848.
DOI
2022 Thompson, W., & Reeve, E. (2022). Deprescribing: moving beyond barriers and facilitators. Research in Social and Administrative Pharmacy, 18(3), 2547-2549.
DOI
2022 Ailabouni, N. J., Reeve, E., Helfrich, C. D., Hilmer, S. N., & Wagenaar, B. H. (2022). Leveraging implementation science to increase the translation of deprescribing evidence into practice. Research in Social and Administrative Pharmacy, 18(3), 2550-2555.
DOI
2022 Weir, K. R., Ailabouni, N. J., Schneider, C. R., Hilmer, S. N., & Reeve, E. (2022). Consumer attitudes towards deprescribing: a systematic review and meta-analysis. The journals of gerontology. Series A, Biological sciences and medical sciences, 77(5), 1020-1034.
DOI
2022 Kouladjian O'Donnell, L., Reeve, E., & Hilmer, S. N. (2022). Development, validation and evaluation of the goal-directed medication review electronic decision support system (G-MEDSS)©. Research in Social and Administrative Pharmacy, 18(7), 3174-3183.
DOI
2022 Kennie Kaulbach, N., Kehoe, S., Whelan, A. M., Reeve, E., Bai, I., Burgess, S., . . . Isenor, J. E. (2022). Use of a knowledge exchange event strategy to identify key priorities for implementing deprescribing in primary healthcare in Nova Scotia, Canada. Evidence and Policy, 18(3), 619-630.
DOI
2022 White, A., Fulda, K. G., Blythe, R., Chui, M. A., Reeve, E., Young, R., . . . Xiao, Y. (2022). Defining and enhancing collaboration between community pharmacists and primary care providers to improve medication safety. Expert Opinion on Drug Safety, 21(11), 1357-1364.
DOI WoS16 Europe PMC13
2021 Jungo, K. T., Mantelli, S., Rozsnyai, Z., Missiou, A., Reeve, E., & Streit, S. (2021). General practitioners' deprescribing decisions in older adults with polypharmacy: a case vignette study in 31 countries. BMC Geriatrics, 21(1, article no. 19), 1-12.
DOI Scopus32 WoS32 Europe PMC30
2021 Ailabouni, N. J., Hilmer, S. N., Kalisch, L., Braund, R., & Reeve, E. (2021). COVID-19 pandemic: considerations for safe medication use in older adults with multimorbidity and polypharmacy. The journals of gerontology. Series A, Biological sciences and medical sciences, 76(6), 1068-1073.
DOI Scopus17 WoS15 Europe PMC18
2021 Green, A. R., Boyd, C. M., Gleason, K. S., Wright, L., Kraus, C. R., Bedoy, R., . . . Bayliss, E. A. (2021). Perspectives on Deprescribing Communication in Primary Care. Journal of General Internal Medicine, 36(4), 1122.
DOI Scopus3 WoS3 Europe PMC3
2021 Jungo, K. T., Meier, R., Valeri, F., Schwab, N., Schneider, C., Reeve, E., . . . Streit, S. (2021). Baseline characteristics and comparability of older multimorbid patients with polypharmacy and general practitioners participating in a randomized controlled primary care trial. BMC Family Practice, 22(article number: 123), 1-14.
DOI
2021 Lo, S. Y., Reeve, E., Page, A. T., Zaidi, S. T. R., Hilmer, S. N., Etherton Beer, C., . . . Naganathan, V. (2021). Attitudes to drug use in residential aged care facilities: a cross-sectional survey of nurses and care staff. Drugs and Aging, 38(8), 697-711.
DOI
2021 Sawan, M., Kouladjian O'Donnell, L., Reeve, E., Gnjidic, D., Chen, T. F., Kelly, P. J., . . . Hilmer, S. N. (2021). The utility of a computerised clinical decision support system intervention in home medicines review: a mixed-methods process evaluation. Research in Social and Administrative Pharmacy, 17(4), 715-722.
DOI Scopus13 Europe PMC9
2021 Kouladjian O'Donnell, L., Gnjidic, D., Sawan, M., Reeve, E., Kelly, P. J., Chen, T. F., . . . Hilmer, S. N. (2021). Impact of the Goal‐directed Medication review Electronic Decision Support System (G‐MEDSS)© on Drug Burden Index: a cluster‐randomised clinical trial in primary care. British Journal of Clinical Pharmacology, 87(3), 1499-1511.
DOI Scopus33 Europe PMC30
2021 Isenor, J. E., Bai, I., Cormier, R., Helwig, M., Reeve, E., Whelan, A. M., . . . Kennie Kaulbach, N. (2021). Deprescribing interventions in primary health care mapped to the Behaviour Change Wheel: a scoping review. Research in Social and Administrative Pharmacy, 17(7), 1229-1241.
DOI
2021 Maher, D., Ailabouni, N., Mangoni, A. A., Wiese, M. D., & Reeve, E. (2021). Alterations in drug disposition in older adults: a focus on geriatric syndromes. Expert Opinion on Drug Metabolism & Toxicology, 17(1), 41-52.
DOI
2021 Roux, B., Sirois, C., Niquille, A., Spinewine, A., Ouellet, N., Petein, C., . . . Reeve, E. (2021). Cross-cultural adaptation and psychometric validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire in French. Research in Social and Administrative Pharmacy, 17(8), 1453-1462.
DOI
2021 Kouladjian O'Donnell, L., Reeve, E., Cumming, A., Scott, I. A., & Hilmer, S. N. (2021). Development and dissemination of the national strategic action plan for reducing inappropriate polypharmacy in older Australians. Internal Medicine Journal, 51(1), 111-115.
DOI
2021 Reeve, E. (2021). Consideration of frailty versus limited life expectancy when deprescribing: a response to: 'LESS CHRON: a tool for deprescribing in patients with multimorbidity'. Journal of Pharmacy Practice and Research, 51(2), 185-186.
DOI
2021 Kua, C. H., Reeve, E., Tan, D. S. Y., Koh, T., Soong, J. L., Sim, M. J. L., . . . Lee, S. W. H. (2021). Patients' and caregivers' attitudes towards deprescribing in Singapore. The Journals of Gerontology: Series A Biological Science and Medical Sciences, 76(6), 1053-1060.
DOI
2020 Rozsnyai, Z., Jungo, K. T., Reeve, E., Poortvliet, R. K. E., Rodondi, N., Gussekloo, J., & Streit, S. (2020). What do older adults with multimorbidity and polypharmacy think about deprescribing? The LESS study - a primary care-based survey. BMC Geriatrics, 20(435), 1-11.
DOI
2020 Achterhof, A. B., Rozsnyai, Z., Reeve, E., Jungo, K. T., Floriani, C., Poortvliet, R. K. E., . . . Streit, S. (2020). Potentially inappropriate medication and attitudes of older adults towards deprescribing. PLoS ONE, 15(10, article no. e0240463), 1-14.
DOI
2020 Bayliss, E. A., Shetterly, S. M., Drace, M. L., Norton, J., Green, A. R., Reeve, E., . . . Boyd, C. M. (2020). The OPTIMIZE patient- and family-centered, primary care-based deprescribing intervention for older adults with dementia or mild cognitive impairment and multiple chronic conditions: study protocol for a pragmatic cluster randomized controlled trial. Trials, 21(1, article no. 542,), 1-13.
DOI Scopus31 WoS25 Europe PMC26
2020 D'Avanzo, B., Agosti, P., Reeve, E., Pasina, L., Sabbà, C., Mannucci, P. M., & Nobili, A. (2020). Views of medical practitioners about deprescribing in older adults: findings from an Italian qualitative study. Maturitas, 134, 29-33.
DOI
2020 Green, A., Boyd, C. M., Gleason, K. S., Wright, L., Kraus, C. R., Bedoy, R., . . . Bayliss, E. A. (2020). Designing a primary care-based deprescribing intervention for patients with dementia and multiple chronic conditions: a qualitative study. Journal of General Internal Medicine, 35(12), 3556-3563.
DOI Scopus37 WoS37 Europe PMC35
2020 Kennie Kaulbach, N., Cormier, R., Kits, O., Reeve, E., Whelan, A. M., Martin Misener, R., . . . Isenor, J. E. (2020). Influencers on deprescribing practice of primary healthcare providers in Nova Scotia: An examination using behavior change frameworks. Medicine Access @ Point of Care, 4, 1-12.
DOI
2020 Gnjidic, D., & Reeve, E. (2020). Deprescribing: what do we know, and where to next?. British Journal of Clinical Pharmacology, 87(3), 722-724.
DOI
2020 O'Donnell, L. K., Sawan, M., Reeve, E., Gnjidic, D., Chen, T. F., Kelly, P. J., . . . Hilmer, S. N. (2020). Erratum: Correction to: Implementation of the goal-directed medication review electronic decision support system (G-MEDSS)© into home medicines review: a protocol for a clusterrandomised clinical trial in older adults (BMC geriatrics (2020) 20 1 (51)). BMC Geriatrics, 20(1), 378.
DOI Europe PMC1
2020 Dearing, M. E., Bowles, S. K., Isenor, J. E., Theou, O., & Reeve, E. (2020). Medication-related criteria in frailty assessment tools: a narrative review. Australasian Journal on Ageing, 39(3), e640-e465.
DOI
2020 Reeve, E. (2020). Deprescribing tools: a review of the types of tools available to aid deprescribing in clinical practice. Journal of Pharmacy Practice and Research, 50(1), 98-107.
DOI
2020 Kouladjian O'Donnell, L., Sawan, M., Reeve, E., Gnjidic, D., Chen, T. F., Kelly, P. J., . . . Hilmer, S. N. (2020). Implementation of the Goal-directed Medication review Electronic Decision Support System (G-MEDSS)© into home medicines review: a protocol for a cluster-randomised clinical trial in older adults. BMC geriatrics, 20(1), 1-12.
DOI Scopus16 Europe PMC11
2020 Sawan, M., Reeve, E., Turner, J., Todd, A., Steinman, M. A., Petrovic, M., & Gnjidic, D. (2020). A systems approach to identifying the challenges of implementing deprescribing in older adults across different health care settings and countries: a narrative review. Expert Review of Clinical Pharmacology, 13(3), 233-245.
DOI Europe PMC71
2020 Dearing, M. E., Bowles, S., Isenor, J., Kits, O., Kouladjian O'Donnell, L., Neville, H., . . . Reeve, E. (2020). Pharmacist-led intervention to improve medication use in older inpatients using the Drug Burden Index: a study protocol for a before/after intervention with a retrospective control group and multiple case analysis. BMJ open, 10(2), e035656.
DOI
2020 Martinez, A. I., Spencer, J., Moloney, M., Badour, C., Reeve, E., & Moga, D. C. (2020). Attitudes toward deprescribing in a middle-aged health disparities population. Research in Social and Administrative Pharmacy, 16(10), 1502-1507.
DOI
2019 Green, A. R., Lee, P., Reeve, E., Wolff, J. L., Chen, C. C. G., Kruzan, R., & Boyd, C. M. (2019). Clinicians' perspectives on barriers and enablers of optimal prescribing in patients with dementia and coexisting conditions. Journal of the American Board of Family Medicine, 32(3), 383-391.
DOI
2019 Gnjidic, D., Ong, H. M. M., Leung, C., Jansen, J., & Reeve, E. (2019). The impact of in hospital patient-education intervention on older people's attitudes and intention to have their benzodiazepines deprescribed: a feasibility study. Therapeutic advances in drug safety, 10, 1-11.
DOI
2019 Reeve, E., Low, L. F., & Hilmer, S. N. (2019). Attitudes of older adults and caregivers in Australia toward deprescribing. Journal of the American Geriatrics Society, 67(6), 12041.
DOI
2019 Farrell, B., Conklin, J., Dolovich, L., Irving, H., Maclure, M., McCarthy, L., . . . Thompson, W. (2019). Deprescribing guidelines: an international symposium on development, implementation, research and health professional education. Research in social and administrative pharmacy, 15(6), 780-789.
DOI
2019 Thompson, W., Reeve, E., Moriarty, F., Maclure, M., Turner, J., Steinman, M. A., . . . Farrell, B. (2019). Deprescribing: future directions for research. Research in social and administrative pharmacy, 15(6), 801-805.
DOI
2019 Laroche, M. L., Sirois, C., Reeve, E., Gnjidic, D., & Morin, L. (2019). Pharmacoepidemiology in older people: purposes and future directions. Therapies, 74(2), 325-332.
DOI
2019 Reeve, E., Farrell, B., Thompson, W., Herrmann, N., Sketris, I., Magin, P. J., . . . Hilmer, S. N. (2019). Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary. Medical journal of Australia, 210(4), 174-179.
DOI
2019 Kroger, E., Simard, M., Sirois, M. J., Giroux, M., Sirois, C., Kouladjian O'Donnell, L., . . . Emond, M. (2019). Is the drug burden index related to declining functional status at follow-up in community-dwelling seniors consulting for minor injuries? Results from the Canadian emergency team initiative cohort study. Drugs and aging, 36(1), 73-83.
DOI
2019 Nguyen, T. A., Gilmartin Thomas, J., Tan, E. C. K., Kalisch Ellett, L., Eshetie, T., Gillam, M., & Reeve, E. (2019). The impact of pharmacist interventions on quality use of medicines, quality of life, and health outcomes in people with dementia and/or cognitive impairment: a systematic review. Journal of Alzheimer's disease, 71(1), 83-96.
DOI Scopus27 WoS25 Europe PMC21
2019 Ailabouni, N. J., & Reeve, E. (2019). Can existing tools predict older adults' willingness to deprescribe? Considerations for D-PRESCRIBE's post-hoc secondary analysis. Research in Social and Administrative Pharmacy, 15(11), 1379-1380.
DOI
2019 Jungo, K. T., Rozsnyai, Z., Mantelli, S., Floriani, C., Reeve, E., & Streit, S. (2019). 'Optimising PharmacoTherapy In the multimorbid elderly in primary CAre' (OPTICA) to improve medication appropriateness: study protocol of a cluster randomised controlled trial. BMJ open, 9(9, article no. e031080), 1-12.
DOI Scopus16 Europe PMC12
2018 Reeve, E., Moriarty, F., Nahas, R., Turner, J. P., Kouladjian O'Donnell, L., & Hilmer, S. N. (2018). A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms. Expert opinion on drug safety, 17(1), 39-49.
DOI
2018 Mantelli, S., Jungo, K. T., Rozsnyai, Z., Reeve, E., Luymes, C. H., Poortvliet, R. K. E., . . . Streit, S. (2018). How general practitioners would deprescribe in frail oldest-old with polypharmacy - the LESS study. BMC family practice, 19(1, article number 169), 1-8.
DOI
2018 Reeve, E., Anthony, A. C., Kouladjian O'Donnell, L., Low, L. F., Ogle, S. J., Glendenning, J. E., . . . Hilmer, S. N. (2018). Development and pilot testing of the revised patients' attitudes towards deprescribing questionnaire for people with cognitive impairment. Australasian journal on ageing, 37(4), E150-E154.
DOI
2018 Okeowo, D., Patterson, A., Boyd, C., Reeve, E., Gnjidic, D., & Todd, A. (2018). Clinical practice guidelines for older people with multimorbidity and life-limiting illness: what are the implications for deprescribing?. Therapeutic advances in drug safety, 9(11), 619-630.
DOI
2018 Reeve, E., Wolff, J. L., Skehan, M., Bayliss, E. A., Hilmer, S. N., & Boyd, C. M. (2018). Assessment of attitudes toward deprescribing in older Medicare beneficiaries in the United States. JAMA Internal medicine, 178(12), 1673-1680.
DOI
2017 Reeve, E., Trenaman, S. C., Rockwood, K., & Hilmer, S. N. (2017). Pharmacokinetic and pharmacodynamic alterations in older people with dementia. Expert opinion on drug metabolism and toxicology, 13(6), 651-667.
DOI
2017 Reeve, E., Thompson, W., & Farrell, B. (2017). Deprescribing: a narrative review of the evidence and practical recommendations for recognizing opportunities and taking action. European journal of internal medicine, 38, 3-11.
DOI
2017 Babar, Z. U. D., Gammie, T. M., Gnjidic, D., Reeve, E., Jordan, V., Hilmer, S. N., . . . Lu, C. Y. (2017). Withdrawal of antihypertensive drugs in older people. Cochrane database of systematic reviews, 2017(2), 2-10.
DOI
2017 Sirois, C., Ouellet, N., & Reeve, E. (2017). Community-dwelling older people's attitudes towards deprescribing in Canada. Research in social and administrative pharmacy, 13(4), 864-870.
DOI
2017 Chan, B., Reeve, E., Matthews, S., Carroll, P. R., Long, J. C., Held, F., . . . Hilmer, S. N. (2017). Medicine information exchange networks among healthcare professionals and prescribing in geriatric medicine wards. British journal of clinical pharmacology, 83(6), 1185-1196.
DOI
2017 Reeve, E., Ong, M., Wu, A., Jansen, J., Petrovic, M., & Gnjidic, D. (2017). A systematic review of interventions to deprescribe benzodiazepines and other hypnotics among older people. European journal of clinical pharmacology, 73(8), 927-935.
DOI
2017 Reeve, E., Molin, P., Hui, A., & Rockwood, K. (2017). Exploration of verbal repetition in people with dementia using an online symptom-tracking tool. International psychogeriatrics, 29(6), 959-966.
DOI
2017 Wu, A., Reeve, E., Hilmer, S., & Gnjidic, D. (2017). Hospital pharmacists' beliefs about optimising statin therapy in older inpatients. Journal of pharmacy practice and research, 47(3), 223-227.
DOI
2017 Reeve, E., & Hilmer, S. (2017). Tapering or abrupt cessation of proton pump inhibitors?. European journal of clinical pharmacology, 73(7), 923-924.
DOI
2017 Ong, G., Page, A., Caughey, G., Johns, S., Reeve, E., & Shakib, S. (2017). Clinician agreement and influence of medication-related characteristics on assessment of polypharmacy. Pharmacology Research and Perspectives, 5(3), 1-6.
DOI Scopus10 WoS9 Europe PMC6
2016 Kalogianis, M. J., Wimmer, B. C., Turner, J. P., Tan, E. C. K., Emery, T., Robson, L., . . . Bell, J. S. (2016). Are residents of aged care facilities willing to have their medications deprescribed?. Research in social and administrative pharmacy, 12(5), 784-788.
DOI Scopus62 WoS62 Europe PMC48
2016 Reeve, E., Low, L., Shakib, S., & Hilmer, S. (2016). Development and validation of the revised patients' attitudes towards deprescribing (rPATD) questionnaire: versions for older adults and caregivers. Drugs and Aging, 33(12), 913-928.
DOI Scopus163 WoS158 Europe PMC136
2016 Gilmartin, J. F. M., Nguyen, T. A., Reeve, E., & Tan, E. C. K. (2016). Incorporating research into current pharmacy practice: the future of Australian pharmacy?. Journal of pharmacy practice and research, 46(4), 397-398.
DOI Scopus2
2016 Kouladjian, L., Gnjidic, D., Reeve, E., Chen, T. F., & Hilmer, S. N. (2016). Health care practitioners' perspectives on deprescribing anticholinergic and sedative medications in older adults. Annals of pharmacotherapy, 50(8), 625-636.
DOI
2016 Galazzi, A., Lusignani, M., Chiarelli, M. T., Mannucci, P. M., Franchi, C., Tettamanti, M., . . . Nobili, A. (2016). Attitudes towards polypharmacy and medication withdrawal among older inpatients in Italy. International journal of clinical pharmacy, 38(2), 454-461.
DOI
2016 Reeve, E., Low, L. F., & Hilmer, S. N. (2016). Beliefs and attitudes of older adults and carers about deprescribing of medications: a qualitative focus group study. British journal of general practice, 66(649), e552-e560.
DOI
2016 Thai, M., Reeve, E., Hilmer, S. N., Qi, K., Pearson, S. A., & Gnjidic, D. (2016). Prevalence of statin-drug interactions in older people: a systematic review. European journal of clinical pharmacology, 72(5), 513-521.
DOI
2016 Reeve, E., Denig, P., Hilmer, S. N., & ter Meulen, R. (2016). The ethics of deprescribing in older adults. Journal of bioethical inquiry, 13(4), 581-590.
DOI
2015 Qi, K., Reeve, E., Hilmer, S. N., Pearson, S. A., Matthews, S., & Gnjidic, D. (2015). Older peoples' attitudes regarding polypharmacy, statin use and willingness to have statins deprescribed in Australia. International journal of clinical pharmacy, 37(5), 949-957.
DOI
2015 Thai, M., Hilmer, S., Pearson, S. A., Reeve, E., & Gnjidic, D. (2015). Prevalence of potential and clinically relevant statin-drug interactions in frail and robust older inpatients. Drugs and aging, 32(10), 849-856.
DOI
2015 Reeve, E., Gnjidic, D., Long, J., & Hilmer, S. (2015). A systematic review of the emerging definition of 'deprescribing' with network analysis: implications for future research and clinical practice. British journal of clinical pharmacology, 80(6), 1254-1268.
DOI
2015 Reeve, E., & Turner, J. P. (2015). Patients' perspectives on the brave new word 'deprescribing'. International Journal of Pharmacy Practice, 23(1), 90-91.
DOI
2015 Grzeskowiak, L., Thomas, A., To, J., Phillips, A., & Reeve, E. (2015). Enhancing education activities for health care trainees and professionals using audience response systems: a systematic review. Journal of Continuing Education in the Health Professions, 35(4), 261-269.
DOI Scopus23 WoS21 Europe PMC14
2015 Reeve, E., Wiese, M. D., & Mangoni, A. A. (2015). Alterations in drug disposition in older adults. Expert opinion on drug metabolism & toxicology, 11(4), 491-508.
DOI Scopus94 Europe PMC66
2015 Reeve, E., Andrews, J., Wiese, M., Hendrix, I., Roberts, M., & Shakib, S. (2015). Feasibility of a patient-centered deprescribing process to reduce inappropriate use of proton pump inhibitors. Annals of Pharmacotherapy, 49(1), 29-38.
DOI Scopus76 WoS58 Europe PMC54
2015 Scott, I. A., Hilmer, S. N., Reeve, E., Potter, K., Le Couteur, D., Rigby, D., . . . Martin, J. H. (2015). Reducing inappropriate polypharmacy: the process of deprescribing. JAMA Internal Medicine, 175(5), 827-834.
DOI WoS1084 Europe PMC927
2015 Grzeskowiak, L., Thomas, A., To, J., Reeve, E., & Phillips, A. (2015). Enhancing continuing education activities using audience response systems: a single-blind controlled trial. Journal of Continuing Education in the Health Professions, 35(1), 38-45.
DOI Scopus15 WoS14 Europe PMC7
2015 Reeve, E., Gnjidic, D., & Hilmer, S. (2015). The role of the OncPal deprescribing guideline in end-of-life care. Supportive care in cancer, 23(4), 899.
DOI
2015 Reeve, E., Bell, J. S., & Hilmer, S. N. (2015). Barriers to optimising prescribing and deprescribing in older adults with dementia: a narrative review. Current clinical pharmacology, 10(3), 168-177.
DOI
2014 Reeve, E., Shakib, S., Hendrix, I., Roberts, M., & Wiese, M. (2014). The benefits and harms of deprescribing. Medical Journal of Australia, 201(7), 386-389.
DOI Scopus92 WoS70 Europe PMC60
2014 Tan, E., Visvanathan, R., Hilmer, S., Vitry, A., Quirke, T., Emery, T., . . . Bell, J. (2014). Analgesic use, pain and daytime sedation in people with and without dementia in aged care facilities: a cross-sectional, multisite, epidemiological study protocol. BMJ Open, 4(6), 1-6.
DOI Scopus32 WoS34 Europe PMC26
2014 Reeve, E., Shakib, S., Hendrix, I., Roberts, M., & Wiese, M. (2014). Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process. British Journal of Clinical Pharmacology, 78(4), 738-747.
DOI Scopus302 WoS277 Europe PMC224
2014 Reeve, E., & Wiese, M. D. (2014). Benefits of deprescribing on patients' adherence to medications. International journal of clinical pharmacy, 36(1), 26-29.
DOI
2013 Reeve, E., Wiese, M., Hendrix, I., Roberts, M., & Shakib, S. (2013). People's attitudes, beliefs, and experiences regarding polypharmacy and willingness to deprescribe. Journal of the American Geriatrics Society, 61(9), 1508-1514.
DOI Scopus197 WoS173 Europe PMC153
2013 Reeve, E., To, J., Hendrix, I., Shakib, S., Roberts, M., & Wiese, M. (2013). Patient barriers to and enablers of deprescribing: a systematic review. Drugs and Aging, 30(10), 793-807.
DOI Scopus415 WoS393 Europe PMC344
2013 Reeve, E., Shakib, S., Hendrix, I., Roberts, M., & Wiese, M. (2013). Development and validation of the patients' attitudes towards deprescribing (PATD) questionnaire. International Journal of Clinical Pharmacy, 35(1), 51-56.
DOI Scopus94 WoS89 Europe PMC83
2012 Reeve, E., & Wiese, M. D. (2012). Difficulties reducing inappropriate prescribing of proton pump inhibitors in the elderly. Drugs & aging, 29(11), 925-926.
DOI

  • Optimal Medication Management in Alzheimer's Disease and Dementia, National Institutes of Health, 04/01/2019 - 31/01/2022

  • Consumer and clinician led priority setting for the NNIDR MEDicines and DEMentia (MEDDEM) National Research Action Plan, Australian Association of Gerontology Research Trust, 01/01/2020 - 21/12/2021

  • Development and implementation of evidence-based deprescribing guidelines to guide person-centred care for people with dementia, NHMRC - ARC Dementia Research Development Fellowship, 01/02/2016 - 28/02/2021

  • Use of antipsychotic medicines for people aged 65 years and over: A review undertaken for the Australian Commission on Safety and Quality in Health Care, Northern Sydney Area Health Service, 15/04/2019 - 29/11/2019

Connect With Me

External Profiles

Other Links